A detailed history of Fmr LLC transactions in Axogen, Inc. stock. As of the latest transaction made, Fmr LLC holds 21,227 shares of AXGN stock, worth $281,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,227
Previous 21,719 2.27%
Holding current value
$281,682
Previous $175,000 12.57%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$5.67 - $8.06 $2,789 - $3,965
-492 Reduced 2.27%
21,227 $153,000
Q1 2024

May 13, 2024

BUY
$6.63 - $10.69 $78,121 - $125,960
11,783 Added 118.59%
21,719 $175,000
Q4 2023

Feb 13, 2024

BUY
$3.61 - $7.76 $24,641 - $52,969
6,826 Added 219.49%
9,936 $67,000
Q3 2023

Nov 13, 2023

BUY
$4.68 - $9.26 $1,053 - $2,083
225 Added 7.8%
3,110 $15,000
Q2 2023

Aug 11, 2023

BUY
$8.5 - $10.38 $1,181 - $1,442
139 Added 5.06%
2,885 $26,000
Q1 2023

May 11, 2023

BUY
$7.53 - $10.95 $1,219 - $1,773
162 Added 6.27%
2,746 $25,000
Q4 2022

Feb 13, 2023

SELL
$9.44 - $13.09 $1,519 - $2,107
-161 Reduced 5.87%
2,584 $25,000
Q3 2022

Nov 10, 2022

BUY
$8.14 - $12.25 $4,257 - $6,406
523 Added 23.54%
2,745 $33,000
Q2 2022

Aug 12, 2022

BUY
$6.99 - $10.0 $11,358 - $16,250
1,625 Added 272.19%
2,222 $18,000
Q1 2022

May 13, 2022

BUY
$7.26 - $10.7 $4,152 - $6,120
572 Added 2288.0%
597 $5,000
Q4 2021

Feb 14, 2022

SELL
$8.8 - $16.0 $2,763 - $5,024
-314 Reduced 92.63%
25 $0
Q3 2021

Nov 15, 2021

BUY
$15.23 - $21.72 $380 - $543
25 Added 7.96%
339 $5,000
Q2 2021

Aug 13, 2021

BUY
$17.8 - $23.5 $5,589 - $7,379
314 New
314 $6,000

Others Institutions Holding AXGN

About Axogen, Inc.


  • Ticker AXGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 42,283,700
  • Market Cap $561M
  • Description
  • AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...
More about AXGN
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.